Maria Neverova, MD
Hospitalist · Greenville, NCNPI 1770773921
Payments from drug & device makers
Across 108 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$329
- AbbVie$328
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$211
- Johnson & Johnson$186
- Melinta Therapeutics, LLC$142
- Merck$142
- plus $718 from 16 others
What the payments were for
- Food & beverage$2,056100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 12 | $329 |
| AbbVie(2 entities) | 20 | $328 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $211 |
| Johnson & Johnson | 12 | $186 |
| Melinta Therapeutics, LLC | 6 | $142 |
| Merck | 8 | $142 |
| E.r. Squibb & Sons, L.L.C. | 7 | $111 |
| Pfizer | 7 | $99 |
| AstraZeneca | 4 | $72 |
| Stryker | 2 | $53 |
| Insmed, Inc. | 2 | $50 |
| Gilead | 3 | $49 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
| Novartis | 2 | $42 |
| Alkermes, Inc. | 2 | $40 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $27 |
| Boehringer Ingelheim | 1 | $26 |
| Recor Medical Inc | 1 | $25 |
| UCB, Inc. | 1 | $25 |
| Amgen | 1 | $20 |
| Urgo Medical North America, LLC | 1 | $20 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $11 |
How this compares
$2,056 in reported general payments places this provider in the 85th percentile of 879 hospitalist providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydralazine Hcl | 21 | $276 |
| Pantoprazole Sodium | 29 | $230 |
| Gabapentin | 12 | $147 |
| Furosemide | 30 | $133 |
| Atorvastatin Calcium | 14 | $103 |
| Metoprolol Succinate | 11 | $92 |
| Metoprolol Tartrate | 20 | $88 |
| Amlodipine Besylate | 20 | $84 |
| Metronidazole | 11 | $71 |
| Doxycycline Hyclate | 11 | $58 |
| Carvedilol | 17 | $57 |
| Ciprofloxacin Hcl | 12 | $47 |
| Lisinopril | 17 | $44 |
Paid to pharmacies, not to this prescriber.
Other hospitalist in Greenville
- Dwan VarnerGreenville$59K
- Neha DoctorGreenville$6K
- Kevin CannonWilmington$47.5M
- Emily Ray KoDurham$182K
- Mahesh ChandrasekharWinston Salem$100K
- Adaorah OkaforWinston Salem$53K
- Honnie SpencerSalisbury$50K
- Jenna BrooksCharlotte$24K
- Ria DancelChapel Hill$13K
- Javad MonzavifarCharlotte$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.